DVA vs LGN · P/E 14, rev $12.82B vs rev $708.0M
DaVita HealthCare Partners Inc (DVA) versus Legence Corp. Class A Common stock (LGN) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Legence Corp. Class A Common stock (LGN) is a engineering & construction company listed on NASDAQ.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported LGN revenue for 2025-09-30 was $708.0M. Net income was $379.0K. Revenue was up 26.2% from 2024-09-30 to 2025-09-30. LGN currently screens at market cap $14.66B.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. LGN currently screens at market cap $14.66B.
Not investment advice. Open the DVA and LGN stock pages for the full models.
Not investment advice.